slides · global inventory
Diagram
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 23,622
Current window 11,671-11,700
Pages 788
Rows per page 30
Component
11,671-11,700 of 23,622
09
The slide uses an infinity loop diagram to represent the interconnected nature of the three platforms.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Solution1 hit
10
The slide uses a bottom-up flow to connect capabilities to strategic outcomes (Speed, Safety, Cost, Quality, Efficacy).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Solution1 hit
18
The slide uses a process flow diagram to illustrate the scaling of manufacturing capacity.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Product1 hit
26
Includes a biological mechanism diagram showing how HDAC6 inhibitors target multiple pathways leading to diastolic dysfunction and HFpEF.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
27
The slide outlines a proprietary R&D pipeline for identifying and validating drug targets using patient-derived cells and machine learning.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
34
Includes a biological mechanism diagram and a line chart showing Ejection Fraction improvement in murine models.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
36
The slide uses a timeline-based table for programs and an infographic for platforms.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank 1 hit
06
The slide uses a process flow to explain the 'Learning' phase of their technology platform.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
07
The slide title is likely a continuation from a previous slide (e.g., '...to treat patients who are not eligible for standard therapies').TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
08
Uses a before-after-bridge style logic to illustrate the clinical advantage of multiplexing.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a color-coded legend to distinguish between liquid and solid tumor programs.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
12
Uses a before-after-bridge framework to contrast current therapy limitations with TScan's solution.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
13
The slide uses a process flow diagram to explain a proprietary biotechnology platform.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
14
The slide uses a Venn diagram to explain the scope of their target discovery platform.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
17
The slide illustrates a dual-platform approach to TCR discovery and validation.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
18
The slide uses a flow-chart style diagram to position TScan's technology as an evolution of current standard-of-care cell therapies.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
22
Uses a process flow diagram to show the patient journey and the specific point of failure (relapse).TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
23
The slide uses a circular process flow to show the interaction between the patient's condition and the donor-derived TCR therapy.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank 1 hit
27
The slide uses a process flow to explain patient stratification for a clinical trial.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · Traction1 hit
29
Uses a Venn diagram to show overlap in Head & Neck cancers, and a central 'ImmunoBank' repository feeding into multiplexed TCR-T arms.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · Traction1 hit
31
The chart shows fold-enrichment of protein fragments, highlighting a 'Novel Head & Neck Target' alongside positive controls.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · Traction1 hit
32
The chart shows fold-enrichment of protein fragments, highlighting three specific targets identified from patient data.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · Traction1 hit
36
The slide uses a process flow to explain the mechanism of action for the company's platform.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank 1 hit
38
The slide uses a diagram to illustrate the mechanism of the T-Integrate system (transposon/transposase integration into T cell DNA).TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank 1 hit
40
Uses a honeycomb/hexagonal diagram to represent the three focus areas.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank 1 hit
42
The slide uses a hexagonal diagram to represent disease areas (Oncology, Infectious Disease, Autoimmune Disease).TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank 1 hit
06
The chart combines a bar chart for studio counts with a timeline overlay for acquisition events.Xponential | IPO Presentation Deck | 44 slides · Xponential Fitness
Pitch deck Investment bank Beat · Early StrugglesLoop · Logic Chain1 hit
11
The slide uses a circular arrow graphic to connect the three pillars of their values-focused business model.Zevia | IPO Presentation Deck | 46 slides · Zevia
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
18
The slide uses a hub-and-spoke diagram to center the brand identity around its core values.Zevia | IPO Presentation Deck | 46 slides · Zevia
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
33
The slide uses a funnel metaphor to represent the customer journey stages.Zevia | IPO Presentation Deck | 46 slides · Zevia
Pitch deck Investment bank Loop · Cost Of Inaction1 hit